|本期目录/Table of Contents|

[1]麻继丹,张锰,王剑,等.携带MYH7基因突变的HCM或DCM儿童临床特点及基因突变分析[J].国际心血管病杂志,2023,03:175-180.
 MA JidanZHANG MengWANG JianLI FenFU LijunGAO WeiLIU TingliangZHANG YuqiSHEN Jie ..Clinical features and genetic profile in hypertrophic or dilated cardiomyopathy children with MYH7 gene mutation[J].International Journal of Cardiovascular Disease,2023,03:175-180.
点击复制

携带MYH7基因突变的HCM或DCM儿童临床特点及基因突变分析(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年03期
页码:
175-180
栏目:
临床研究
出版日期:
2023-05-30

文章信息/Info

Title:
Clinical features and genetic profile in hypertrophic or dilated cardiomyopathy children with MYH7 gene mutation?
作者:
麻继丹张锰王剑李奋傅立军高伟刘廷亮张玉奇沈捷
200127 上海交通大学医学院附属上海儿童医学中心心内科(麻继丹,张锰,李奋,傅立军,高伟,刘廷亮,张玉奇,沈捷),遗传分子诊断科(王剑)
Author(s):
MA Jidan12ZHANG Meng12WANG Jian12LI Fen12FU Lijun12GAO Wei12LIU Tingliang12ZHANG Yuqi12SHEN Jie 1.12
1.Department of Cardiology, ShanghaiChildren'2.s Medical Centre, Shanghai Jiao Tong University School of Medicine, Shanghai? 200127
关键词:
肥厚型心肌病扩张型心肌病MYH7
Keywords:
Hypertrophic cardiomyopathy Dilated cardiomyopathy MYH7
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.03.012
文献标识码:
-
摘要:
目的:比较有MYH7基因突变的肥厚型心肌病(HCM)与扩张型心肌病(DCM)患儿的临床特征及基因突变特点,探讨MYH7基因突变对心肌病临床表型的影响。方法:回顾性分析2015年1月至2021年1月,在上海儿童医学中心通过基因检测发现携带MYH7基因突变的30例HCM或DCM患者,收集并分析2组不同心肌病患儿的临床资料与基因突变信息。结果:30例有MYH7基因突变患儿中检出32个突变位点,共26种不同突变位点,其中10种为国内外未报道的突变位点。29个(90.6%)突变位点为错义突变,30个(93.7%)突变位点位于肌球蛋白头颈部。在30例MYH7基因突变患儿中,HCM患儿21例(70%),DCM患儿9例(30%)。2组患儿在性别,诊断年龄,阳性家族史,N末端脑钠肽前体、心肌肌钙蛋白Ⅰ、肌酸激酶同工酶以及血清钙离子水平,心电图异常等方面的差异无统计学意义。结论:不同位点的MYH7基因突变可引起HCM或DCM完全不同的临床表型,在儿童期或疾病早期临床表现无明显差异。
Abstract:
Objective: To compare clinical features and genetic profile between hypertrophic (HCM) or dilated cardiomyopathy (DCM) children with MYH7 gene mutation, and to explore the potential role of this gene mutation in different phenotypes of cardiomyopathy.? Methods: Clinical data and gene mutation profile were retrospectively collected from Shanghai Children's Medical Center between January 2015 and January 2021, and were compared among HCM and DCM children with MYH7 gene mutation. ? Results: There were 21 cases of HCM (70%) and 9 cases of DCM (30%) with MYH7 gene mutation. A total of 32 mutation sites (including 26 different types) were detected, 10 of which were not reported previously. 29 (90.6%) mutation sites were missense mutations, and 30 (93.7%) mutation sites were located atthe head and neck of myoglobin. HCM and DCM children with MYH7 gene mutation did not significantly differ with respect to gender, age, family history, plasma concentrations of NT-proBNP, cTnI, CK-MB and calcium, and electrocardiographic abnormalities.? Conclusion:MYH7 gene mutation could cause different phenotypes of HCM or DCM. There is no significant difference in clinical manifestations during childhood or early stage of the disease.

参考文献/References

[1]Marian AJ, Braunwald E. Hypertrophic cardiomyopathy:genetics, pathogenesis, clinical manifestations, diagnosis, and therapy[J]. Circ Res, 2017, 121(7):749-770.
[2]McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms[J]. Circ Res, 2017, 121(7):731-748.
[3]Walsh R, Rutland C, Thomas R, et al. Cardiomyopathy: a systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestations[J]. Cardiology, 2010, 115(1):49-60.
[4]Smith KM, Squiers J. Hypertrophic cardiomyopathy: an overview[J]. Crit Care Nurs Clin North Am, 2013, 25(2):263-272.
[5]Park HY. Hereditary dilated cardiomyopathy: recent advances in genetic diagnostics[J]. Korean Circ J, 2017, 47(3):291-298.
[6]Tanjore R, Rangaraju A, Vadapalli S, et al. Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy[J]. Indian J Hum Genet, 2010, 16(2):67-71.
[7]Grenier MA, Osganian SK, Cox GF, et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry[J]. Am Heart J, 2000, 139(2):s86-s95.
[8]Fatkin D, Christe ME, Aristizabal O, et al. Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene[J]. J Clin Invest, 1999, 103(1):147-153.
[9]McConnell BK, Fatkin D, Semsarian C, et al. Comparison of two murine models of familial hypertrophic cardiomyopathy[J]. Circ Res, 2001, 88(4):383-389.
[10] Kayvanpour E, Sedaghat-Hamedani F, Amr A, et al. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals[J]. Clin Res Cardiol, 2017, 106(2):127-139.
[11] Hershkovitz T, Kurolap A, Ruhrman-Shahar N, et al. Clinical diversity of MYH7-related cardiomyopathies: insights into genotype-phenotype correlations[J]. Am J Med Genet A, 2019, 179(3):365-372.
[12] Girolami F, Passantino S, Verrillo F, et al. The influence of genotype on the phenotype, clinical course, and risk of adverse events in children with hypertrophic cardiomyopathy[J]. Heart Fail Clin, 2022, 18(1):1-8.
[13] Dadson K, Hauck L, Billia F. Molecular mechanisms in cardiomyopathy[J]. Clin Sci (Lond), 2017, 131(13):1375-1392.
[14] Wijnker PJM, van der Velden J. Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(8):165774.
[15] Ren XF, Hensley N, Brady MB, et al. The genetic and molecular bases for hypertrophic cardiomyopathy: the role for calcium sensitization[J]. J Cardiothorac Vasc Anesth, 2018, 32(1):478-487.
[16] Montag J, Kowalski K, Makul M, et al. Burst-like transcription of mutant and wildtype MYH7-alleles as possible origin of cell-to-cell contractile imbalance in hypertrophic cardiomyopathy[J]. Front Physiol, 2018, 9:359.
[17] Alves ML, Gaffin RD, Wolska BM. Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes[J]. J Mol Cell Cardiol, 2010, 48(5):834-842.
[18] Pagiatakis C, Di Mauro V. The emerging role of epigenetics in therapeutic targeting of cardiomyopathies[J]. Int J Mol Sci, 2021, 22(16):8721.
[19] Jordan DM, Kiezun A, Baxter SM, et al. Development and validation of a computational method for assessment of missense variants in hypertrophic cardiomyopathy[J]. Am J Hum Genet, 2011, 88(2):183-192.
[20] Lu CX, Wu W, Liu F, et al. Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies[J]. J Transl Med, 2018, 16(1):241.

备注/Memo

备注/Memo:
通信作者:沈捷, E-mail:she6nt@163.com
更新日期/Last Update: 2023-05-30